Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq

Diabetes, Metabolic Syndrome and Obesity

Volumn 7, Issue , 2014, Pages 139-144

  Mansour, Abbas Ali ^a   Al Maliky, Ahmed A ^a   Kasem, Bashar ^a   Jabar, Abdulsatar ^a   Mosbeh, Khalid Abdulabass ^a  

^a Al Faiha Diabetes Endocrine and Metabolism Center (FDEMC) Basrah   (Iraq)

Author keywords

Diabetes mellitus; Epidemiology; Glycated hemoglobin; Iraq; Screening

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DYSGLYCEMIA; EPIDEMIC; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IRAQ; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; SCREENING; SEX DIFFERENCE; SMOKING;

EID: 84899872006     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S59652     Document Type: Article

References (27)

1. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011. Available from: http://www.idf.org/diabetesatlas/5e/the-global-burden. Accessed March 24, 2014.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62-S69.
3. Selvin E, Steffes MW, Zhu H, etal. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9): 800-811.
4. 1c in the diagnosis of diabetes mellitus in Australia. Med J Aust. 2012;197(4):220-221.
5. Seino Y, Nanjo K, Tajima N, etal. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Japan Diab Soc. 2010;53:450-467.
6. Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K; DETECT-2 Collaboration Writing Group. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care. 2011;34(1):145-150.
7. 1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334.
8. [No authors listed]. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-853.
9. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, etal. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 2012;380(9855):1741-1748.
10. Mansour AA, Wanoose HL, Hani I, Abed-Alzahrea A, Wanoose HL. Diabetes screening in Basrah, Iraq: a population-based cross-sectional study. Diabetes Res Clin Pract. 2008;79(1):147-150.
11. Boutayeb A, Lamlili M, Boutayeb W, Maamri A, Ziyyat A, Ramdani N. The rise of diabetes prevalence in the Arab region. Open J Epidemiol. 2012;2:55-60.
12. World Health Organization. Global Infobase. Available from: https://apps.who.int/infobase/CountryProfiles.aspx. Accessed October 1, 2012.
13. Bennet L, Johansson SE, Agardh CD, etal. High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighborhood-a population based study. BMC Public Health. 2011;11:303.
14. Al-Daghri NM, Al-Attas OS, Alokail MS, etal. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011;9:76.
15. Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med. 2011;31(1):19-23.
16. Hamadeh RR. Non communicable diseases among the Bahraini population: a review. East Mediterr Health J. 2000;6(5-6):1091-1097.
17. Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002;19(11): 954-957.
18. Hirbli KI, Jambeine MA, Slim HB, Barakat WM, Habis RJ, Francis ZM. Prevalence of diabetes in greater Beirut. Diabetes Care. 2005;28(5):1262.
19. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, etal. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571-576.
20. Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health. 2008;8:176.
21. Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications. 2008;22(5):317-324.
22. Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J. 2000;6(1):43-52.
23. Saadi H, Al-Kaabi J, Benbarka M, etal. Prevalence of undiagnosed diabetes and quality of care in diabetic patients followed at primary and tertiary clinics in Abu Dhabi, United Arab Emirates. Rev Diabet Stud. 2010;7(4):293-302.
24. MENA International Diabetes Federation. Diabetes: the Hidden Pandemic and its Impact on the Middle East and Northern Africa. 2010. Available from: http://www.novonordisk.com/images/about_us/changing-diabetes/PDF/Leadership%20forum%20pdfs/MENA%20Forum/MENA_Diabetes_briefing_book_EN.pdf. Accessed April 17, 2014.
25. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care. 1999;22(3):394-398.
26. [No authors listed]. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7): 1183-1197.
27. Kuzuya T, Nakagawa S, Satoh J, etal; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetes Res Clin Pract. 2002;55(1):65-85.